Hepatitis B virus reactivation during immunosuppressive therapy: Appropriate risk stratification

doi:10.4254/wjh.v7.i6.825

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 6

This Article

(372)

(314)

(0)

(6340)

(20)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Editorial

World J Hepatol. Apr 28, 2015; 7(6): 825-830
Published online Apr 28, 2015. doi: 10.4254/wjh.v7.i6.825

Table 1 Immunosuppressive regimens known to increase risk of hepatitis B virus reactivation

HBsAg-positive	HBsAg-negative
	Anti-HBc positive
Corticosteroids	Anti-CD20 (e.g., rituximab)
Anti-CD20 (e.g., rituximab)	HSCT
HSCT	Anti-TNF
Anti-TNF	TACE for hepatocellular carcinoma
Anthracyclines	Methotrexate
TACE for hepatocellular carcinoma
Methotrexate
Ustekinumab
Tyrosine kinase inhibitors

HBsAg: Hepatitis B surface antigen; Anti-HBc: Antibody to hepatitis B core antigen; Anti-CD20: Antibody against CD20; Anti-TNF: Antibody against tumor necrosis factor; TACE: Transarterial chemo-embolization; HSCT: Hematopoietic stem cell transplantation.

Full Size Table

Citation: Seto WK. Hepatitis B virus reactivation during immunosuppressive therapy: Appropriate risk stratification. World J Hepatol 2015; 7(6): 825-830
URL: https://www.wjgnet.com/1948-5182/full/v7/i6/825.htm
DOI: https://dx.doi.org/10.4254/wjh.v7.i6.825

Seto WK. Hepatitis B virus reactivation during immunosuppressive therapy: Appropriate risk stratification. World J Hepatol 2015; 7(6): 825-830 [PMID: 25937860 DOI: 10.4254/wjh.v7.i6.825]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.